Breaking News Instant updates and real-time market news.

AZRX

AzurRx BioPharma

$2.60

0.185 (7.68%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50

AzurRx BioPharma surpasses 50% enrollment for Phase 2 OPTION study

AzurRx BioPharma announced that it has now surpassed the 50% enrollment target in its ongoing Phase II OPTION study of MS1819-SD for exocrine pancreatic insufficiency in patients with cystic fibrosis, or CF. The Phase II multi-center OPTION study is designed to investigate the safety, tolerability and efficacy of MS1819-SD in a head-to-head comparison against the current porcine pancreatic enzyme replacement therapy, or PERT, standard of care for exocrine pancreatic insufficiency in CF patients. Planned enrollment is expected to include approximately 30 CF patients, with top-line results expected in summer.

  • 30

    Apr

AZRX AzurRx BioPharma
$2.60

0.185 (7.68%)

10/17/18
10/17/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ulta Beauty (ULTA) initiated with a Buy at Argus. 2. Principal Financial (PFG) initiated with a Hold at Deutsche Bank. 3. MongoDB (MDB) initiated with an Outperform at Oppenheimer. 4. Simply Good Foods (SMPl) initiated with a Buy at Buckingham. 5. AzurRx BioPharma (AZRX) initiated with an Outperform at Oppenheimer. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/25/19
ROTH
01/25/19
INITIATION
Target $10.5
ROTH
Buy
AzurRx BioPharma initiated with a Buy at Roth Capital
Roth Capital analyst Jerry Isaacson initiated AzurRx BioPharma with a Buy rating and $10.50 price target. In a research note to investors, Isaacson says he assumes MS1819 to treat EPI in CF patients will be approved for the patient population in 2022, and says his model includes pricing starting at $18,000 per patient per year, in line with currently approved PERTs. MS1819 has numerous potential advantages over currently approved treatments, including reduced pill burden, and the fact that it is not derived from an animal source, he adds.
01/25/19
01/25/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. SS&C (SSNC) initiated with a Buy at Buckingham. 2. Capital Southwest (CSWC) initiated with a Neutral at B. Riley FBR. 3. Natural Gas Services (NGS) initiated with a Buy at Maxim. 4. Aptose Biosciences (APTO) initiated with an Outperform at Oppenheimer. 5. AzurRx BioPharma (AZRX) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/14/19
MAXM
02/14/19
INITIATION
Target $5
MAXM
Buy
AzurRx BioPharma initiated with a Buy at Maxim
Maxim analyst Caroline Palomeque initiated AzurRx BioPharma with a Buy rating and a price target of $5. The analyst cites the company's prioritizing of MS1819-SD development in Cystic Fibrosis given the "relatively undifferentiated" Pancreatic Enzyme Replacement Therapy market, stating the drug would be the "first non-porcine product available for exocrine pancreatic insufficiency that lowers pill burden, reduces risk of allergic reaction and improves quality of life".

TODAY'S FREE FLY STORIES

FTS

Fortis

$41.21

0.19 (0.46%)

09:10
08/22/19
08/22
09:10
08/22/19
09:10
Downgrade
Fortis rating change  »

Fortis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 11

    Nov

APEX

Apex Global Brands

$0.52

-0.0187 (-3.47%)

09:10
08/22/19
08/22
09:10
08/22/19
09:10
Hot Stocks
Apex Global Brands expands Tony Hawk brand through licensing agreements »

APEX Global Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JE

Just Energy

$1.19

-0.14 (-10.57%)

09:10
08/22/19
08/22
09:10
08/22/19
09:10
Upgrade
Just Energy rating change  »

Just Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:10
08/22/19
08/22
09:10
08/22/19
09:10
General news
Fedspeak from Jackson Hole: »

Fedspeak from Jackson…

AOSL

Alpha & Omega

$12.84

0.06 (0.47%)

09:10
08/22/19
08/22
09:10
08/22/19
09:10
Recommendations
Alpha & Omega analyst commentary  »

Alpha & Omega price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 11

    Sep

  • 12

    Sep

RBZ

Reebonz Holding

$2.20

0.42 (23.60%)

09:09
08/22/19
08/22
09:09
08/22/19
09:09
Hot Stocks
Reebonz Holding announces sell back guarantee data »

Reebonz Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPG

Washington Prime

$3.31

0.07 (2.16%)

09:08
08/22/19
08/22
09:08
08/22/19
09:08
Conference/Events
Washington Prime management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

09:08
08/22/19
08/22
09:08
08/22/19
09:08
Hot Stocks
Dick's Sporting sells Affinity Sports, Blue Sombrero to Stack Sports »

Stack Sports announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

SEEL

Seelos Therapeutics

$1.66

-0.03 (-1.78%)

09:07
08/22/19
08/22
09:07
08/22/19
09:07
Hot Stocks
Seelos Therapeutics announces FDA acceptance of IND application for SLS-005 »

Seelos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

$228.75

3 (1.33%)

09:06
08/22/19
08/22
09:06
08/22/19
09:06
Conference/Events
Air Products management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

TGT

Target

$103.11

17.54 (20.50%)

09:06
08/22/19
08/22
09:06
08/22/19
09:06
Recommendations
Target analyst commentary  »

Target price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

LRAD

LRAD Corporation

$3.64

0.195 (5.66%)

09:05
08/22/19
08/22
09:05
08/22/19
09:05
Hot Stocks
LRAD Corporation announces $1M in new defense orders »

LRAD Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWOU

2U

$18.60

0.21 (1.14%)

09:05
08/22/19
08/22
09:05
08/22/19
09:05
Hot Stocks
2U announces retirement of CFO Catherine Graham »

2U announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$13.87

0.2 (1.46%)

09:05
08/22/19
08/22
09:05
08/22/19
09:05
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Oct

  • 12

    Dec

  • 16

    Dec

PSTG

Pure Storage

$13.87

0.2 (1.46%)

09:04
08/22/19
08/22
09:04
08/22/19
09:04
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Oct

  • 12

    Dec

  • 16

    Dec

APEI

American Public Education

$26.95

0.28 (1.05%)

09:04
08/22/19
08/22
09:04
08/22/19
09:04
Hot Stocks
American Public Education appoints Angela Selden as CEO effective September 23 »

American Public Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBLT

ToughBuilt

$0.38

-0.0162 (-4.14%)

, AMZN

Amazon.com

$1,823.19

21.11 (1.17%)

09:04
08/22/19
08/22
09:04
08/22/19
09:04
Hot Stocks
ToughBuilt announces launch of Amazon storefronts as part of global expansion »

ToughBuilt Industries…

TBLT

ToughBuilt

$0.38

-0.0162 (-4.14%)

AMZN

Amazon.com

$1,823.19

21.11 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AMGN

Amgen

$203.84

0.69 (0.34%)

, AGN

Allergan

$161.32

2.1 (1.32%)

09:03
08/22/19
08/22
09:03
08/22/19
09:03
Hot Stocks
Amgen, Allergan announce 'positive' results from study of ABP 798 »

Amgen (AMGN) and Allergan…

AMGN

Amgen

$203.84

0.69 (0.34%)

AGN

Allergan

$161.32

2.1 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

  • 02

    Oct

LOW

Lowe's

$108.00

9.96 (10.16%)

09:03
08/22/19
08/22
09:03
08/22/19
09:03
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 20

    Nov

HROW

Harrow Health

$5.33

0.15 (2.90%)

09:03
08/22/19
08/22
09:03
08/22/19
09:03
Conference/Events
Harrow Health management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 29

    Aug

  • 12

    Sep

WSTL

Westell Technologies

$1.45

0.02 (1.40%)

09:02
08/22/19
08/22
09:02
08/22/19
09:02
Hot Stocks
Westell Technologies appoints Timothy Duitsman as president, CEO »

Westell Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

SPLK

Splunk

$128.51

1.87 (1.48%)

09:01
08/22/19
08/22
09:01
08/22/19
09:01
Recommendations
Splunk analyst commentary  »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 15

    Oct

SAVE

Spirit Airlines

$38.51

-0.09 (-0.23%)

09:00
08/22/19
08/22
09:00
08/22/19
09:00
Initiation
Spirit Airlines initiated  »

Spirit Airlines resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 13

    Nov

NVCN

Neovasc

$2.97

-0.025 (-0.83%)

08:59
08/22/19
08/22
08:59
08/22/19
08:59
Hot Stocks
Neovasc receives Nasdaq notification on minimum market value deficiency »

Neovasc has received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUTR

Cutera

$32.75

0.76 (2.38%)

08:59
08/22/19
08/22
08:59
08/22/19
08:59
Downgrade
Cutera rating change  »

Cutera downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.